Publication Cover

Annals of the
American Thoracic Society

Publishes clinical trials, original research, ATS documents, systematic reviews, and case conferences in clinical, epidemiological, and health services research related to adult and pediatric pulmonary, respiratory, critical care medicine, sleep, and population health

Annals Animated

News & Announcements

ATS Journals has waived submission fees.
The 2023 impact factors are now available.
In recognition of their exemplary work, the Annals editors are delighted to present the 2023 Journal Reviewer Award winners.
This page highlights the top COVID-19 papers of 2020 from each of the four ATS Journals. The items below were selected by the Editor-in-Chief for each of the journals and are meant to showcase some of the most important and relevant COVID-19 content published in AJRCCM, AJRCMB, AnnalsATS, and ATS Scholar.
COVID-19 is a new form of Coronavirus disease due to the novel virus SARS-CoV2 that causes acute infection with respiratory symptoms. This page will serve as a hub for all COVID-19 related manuscripts published across all four ATS Journals.

Current Issue Highlights

Cardiopulmonary exercise testing (CPET) provides prognostic information in cystic fibrosis (CF); however, its prognostic value for patients with advanced CF lung disease is unknown. The authors sought to determine the prognostic value of CPET on the risk of death or lung transplant (LTX) within 2 years.
MARCH 2024 AnnalsATS
The authors performed a retrospective analysis of chest computed tomography (CT), demographics, longitudinal pulmonary function, and transplantation-free survival among participants in the Pulmonary Fibrosis Foundation Patient Registry. The extent of lung fibrosis by quantitative CT is a strong predictor of physiologic progression and survival, independent of visually assessed CT pattern.
MARCH 2024 AnnalsATS
Severe cases of acute respiratory distress syndrome (ARDS) may require prolonged (>28 d) extracorporeal membrane oxygenation (ECMO). In nonresolving disease, recovery is uncertain, and lung transplant may be proposed. This study aimed to identify the variables influencing survival and to describe the functional status of these patients at 6 months.
MARCH 2024 AnnalsATS

Case Conference

A 51-year-old woman with hypertension, hypercholesterolemia, and type 2 diabetes mellitus presented for worsening dyspnea for more than 1 year accompanied by muscle fatigue. Among her medications were simvastatin and lisinopril.
MARCH 2024 AnnalsATS

Journal Metrics

Impact Factor
Full-Text Views
~3.6 Million
Google h5-index 57
More Metrics